Paper · 41018564
References124
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
1 to 20 of 124
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 35971075 | Primary care physicians' knowledge and attitudes about obesity, adherence to treatment guidelines and association with confidence to treat obesity: a Swedish survey study. | BMC Prim Care | 2022 | https://conductscience.org/library/papers/35971075 | PubMed |
| 2 | 21975647 | Glucagon-like peptide-1 receptor agonists suppress water intake independent of effects on food intake. | Am J Physiol Regul Integr Comp Physiol | 2011 | https://conductscience.org/library/papers/21975647 | PubMed |
| 3 | 37689140 | The effectiveness of medical nutrition therapy provided by a dietitian in adults with prediabetes: a systematic review and meta-analysis. | Am J Clin Nutr | 2023 | https://conductscience.org/library/papers/37689140 | PubMed |
| 4 | 34775881 | Managing the gastrointestinal side effects of GLP-1 receptor agonists in obesity: recommendations for clinical practice. | Postgrad Med | 2022 | https://conductscience.org/library/papers/34775881 | PubMed |
| 5 | 37990727 | Nonalcoholic fatty liver disease and obesity: An Obesity Medicine Association (OMA) Clinical Practice Statement (CPS) 2022. | Obes Pillars | 2022 | https://conductscience.org/library/papers/37990727 | PubMed |
| 6 | 38544798 | Healthy weight loss maintenance with exercise, GLP-1 receptor agonist, or both combined followed by one year without treatment: a post-treatment analysis of a randomised placebo-controlled trial. | EClinicalMedicine | 2024 | https://conductscience.org/library/papers/38544798 | PubMed |
| 7 | 35227529 | Definition and diagnostic criteria for sarcopenic obesity: ESPEN and EASO consensus statement. | Clin Nutr | 2022 | https://conductscience.org/library/papers/35227529 | PubMed |
| 8 | 38085928 | Nutrition and physical activity: An Obesity Medicine Association (OMA) Clinical Practice Statement 2022. | Obes Pillars | 2022 | https://conductscience.org/library/papers/38085928 | PubMed |
| 9 | 37990728 | Cancer and Obesity: An Obesity Medicine Association (OMA) Clinical Practice Statement (CPS) 2022. | Obes Pillars | 2022 | https://conductscience.org/library/papers/37990728 | PubMed |
| 10 | 32753461 | Obesity in adults: a clinical practice guideline. | CMAJ | 2020 | https://conductscience.org/library/papers/32753461 | PubMed |
| 11 | 39726721 | Why are we still in need for novel anti-obesity medications? | Lancet Reg Health Eur | 2024 | https://conductscience.org/library/papers/39726721 | PubMed |
| 12 | 39386160 | Burden of disease attributable to high body mass index: an analysis of data from the Global Burden of Disease Study 2021. | EClinicalMedicine | 2024 | https://conductscience.org/library/papers/39386160 | PubMed |
| 13 | 39710882 | GLP1Ra-based therapies and DXA-acquired musculoskeletal health outcomes: a focused meta-analysis of placebo-controlled trials. | Obesity (Silver Spring) | 2025 | https://conductscience.org/library/papers/39710882 | PubMed |
| 14 | 36458843 | How might enhanced interprofessional collaboration between primary care physicians and registered dietitian nutritionists impact clinical outcomes related to obesity and associated illnesses? A commentary. | Public Health Nutr | 2023 | https://conductscience.org/library/papers/36458843 | PubMed |
| 15 | 33899338 | Weight Can't Wait: A Guide to Discussing Obesity and Organizing Treatment in the Primary Care Setting. | Obesity (Silver Spring) | 2021 | https://conductscience.org/library/papers/33899338 | PubMed |
| 16 | 37518832 | Moving beyond eat less, move more using willpower: Reframing obesity as a chronic disease impact of the 2020 Canadian obesity guidelines reframed narrative on perceptions of self and the patient-provider relationship. | Clin Obes | 2023 | https://conductscience.org/library/papers/37518832 | PubMed |
| 17 | 23225173 | How do we improve patient compliance and adherence to long-term statin therapy? | Curr Atheroscler Rep | 2013 | https://conductscience.org/library/papers/23225173 | PubMed |
| 18 | 39109480 | The latest evidence and clinical guidelines for use of meal replacements in very-low-calorie diets or low-calorie diets for the treatment of obesity. | Diabetes Obes Metab | 2024 | https://conductscience.org/library/papers/39109480 | PubMed |
| 19 | 37661106 | The Weight-loss Effect of GLP-1RAs Glucagon-Like Peptide-1 Receptor Agonists in Non-diabetic Individuals with Overweight or Obesity: A Systematic Review with Meta-Analysis and Trial Sequential Analysis of Randomized Controlled Trials. | Am J Clin Nutr | 2023 | https://conductscience.org/library/papers/37661106 | PubMed |
| 20 | 39582489 | Recent achievements and future directions of anti-obesity medications. | Lancet Reg Health Eur | 2024 | https://conductscience.org/library/papers/39582489 | PubMed |
papers-2026-11-12-0.1.0
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/papers/v1/41018564/references